Patent details

EP1153013 Title: 5-HT1F AGONISTS

Basic Information

Publication number:
EP1153013
PCT Application Number:
PCT/US/2000/002502
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP009157199
PCT Publication Number:
WO/2000/047559
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
5-HT1F AGONISTS
French Title of Invention:
AGONISTES 5-HT1F
German Title of Invention:
5-HT1F AGONISTEN
SPC Number:

Dates

Filing date:
09/02/2000
Grant date:
31/10/2007
EP Publication Date:
31/10/2007
PCT Publication Date:
17/08/2000
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
14/11/2001
EP B1 Publication Date:
31/10/2007
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
09/02/2008
Expiration date:
09/02/2020
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
09/02/2000
 
 

Name:
ELI LILLY AND COMPANY
Address:
Lilly Corporate Center, Indianapolis, Indiana 46285, United States (US)

Inventor

1

Name:
MANCUSO Vincent
Address:
Belgium (BE)

2

Name:
SCHAUS John, Mehnert
Address:
United States (US)

3

Name:
NAPORA Freddy, Andre
Address:
Belgium (BE)

4

Name:
KRUSHINSKI Joseph, Herman, Jr.
Address:
United States (US)

Priority

Priority Number:
119596 P
Priority Date:
10/02/1999
Priority Country:
United States (US)

Classification

Main IPC Class:
C07D 211/22;
Filing date Document type Number of pages